|
HY-114209-1mL
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-153584-10mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-25mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-5mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-50mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-1mL
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6] (10mM in DMSO)
|
|
|
|
|
HY-128358-10mg
|
MedChemexpress LLC
|
MR-L2 [CAS 2374703-19-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128358-5mg
|
MedChemexpress LLC
|
MR-L2 [CAS 2374703-19-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128358-50mg
|
MedChemexpress LLC
|
MR-L2 [CAS 2374703-19-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128358-1mL
|
MedChemexpress LLC
|
MR-L2 [CAS 2374703-19-0] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128773A-10mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-100mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-25mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-5mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-50mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-135280-1mg
|
MedChemexpress LLC
|
MRL-650 [CAS 852315-00-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-119464-10mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-100mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-25mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-5mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-50mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-149167-1mg
|
MedChemexpress LLC
|
mRNA-Encapsulating Lipid Excipient 1 [CAS 2230647-37-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-121119-10mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-100mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-25mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
